Mednet Logo
HomeQuestion

How would you manage a patient with new FDG avid retroperitoneal lymph nodes after completing definitive chemoradiation for stage III anal canal cancer?

2
4 Answers
Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

I agree with @Dr. First Last. PA nodes are not really systemic disease if you consider the disease biology. They are regional nodes. There is 100% RR and >90% LC with chemoradiation with very low risk.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic School of Medicine

I would encourage a thorough assessment of extent of current disease. If disease is controlled within the pelvis and the patient experienced progression out of the prior field, then salvage chemoradiation does offer curative potential. MultiD discussion is key for cases like this. @Dr. First Last, t...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Holliday et al., PMID 29907489.

Largest series showing long term DFS and OS with definitive chemo RT for RP nodes at presentation.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · University of Wisconsin

I would biopsy these nodes. If positive, I would manage with immunotherapy (preferred, see here for supportive trial information https://ascopubs.org/doi/10.1200/JCO.2020.38.4_suppl.1 ) or carboplatin/Taxol (Rao et al., PMID 32530769). Radiation and surgical oncology teams should also be consulted f...

Register or Sign In to see full answer

How would you manage a patient with new FDG avid retroperitoneal lymph nodes after completing definitive chemoradiation for stage III anal canal cancer? | Mednet